PREVIOUS
✖
Treatment for Prostate Cancer
October 20 , 2021
1007 days
795
0
- The Indian Institute of Technology (IIT), Kanpur team identifies a novel target - DLX1 gene - to treat prostate cancer.
- The team has discovered that the DLX1 gene has an important role to play in the growth and development of prostate cancer.
- When the team genetically removed the DLX1 gene that produces the protein, the ability of cancer cells to grow, develop and spread to other parts of the body was compromised.
- The team has further shown that both androgen receptor and fusion gene product ‘ERG’ are responsible for increased levels of DLX1 in prostate cancer cells.
- The team also found that Bromodomain and extra terminal (BET) protein assists the function of both androgen receptor and ERG.
Leave a Reply
Your Comment is awaiting moderation.